查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
白内障手术器械市场 - 增长、趋势、COVID-19 影响和预测 (2023-2028)
市场调查报告书
商品编码
1190243

白内障手术器械市场 - 增长、趋势、COVID-19 影响和预测 (2023-2028)

Cataract Surgery Devices Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计在 2022 年至 2027 年的预测期内，白内障手术器械市场的复合年增长率为 4.2%。

COVID-19 大流行不仅扰乱了 COVID-19 以外的其他治疗方法和药物的研发活动，而且还扰乱了世界各地的治疗方案以及药物和医疗设备供应链。它已经对白内障手术设备市场也有影响。 例如，根据 2021 年 12 月发表的题为“COVID-19 大流行影响白内障手术量”的研究“COVID-19 大流行对白内障手术量的影响”。 根据北印度经验，接受调查的诊所计划进行 7,500 次白内障手术，但由于大流行，只有 2,500 次能够进行。 数据显示，在 COVID-19 大流行期间，白内障手术显着减少。 然而，由于疫苗接种计划的进展和 COVID-19 病例的减少，研究中的市场有望在研究预测期内恢復其全部潜力。

预计将推动白内障手术器械市场增长的主要因素是白内障患病率的增加和世界人口老龄化的加剧。 例如，根据 Xiaotong Han 等人发表的研究结果。 到 2021 年 9 月，全球白内障相关视力障碍患病率将从 1990 年的每 10 万人 791.4 人增加到 2019 年的每 10 万人 1253.9 人，增加 58.45%，这意味着白内障相关的残疾调整生命年 (DALYs) 增加了 58.45%从1990年的每10万人65.3人增加了32.18%到2019年的每10万人86.3人，表明全球白内障和白内障相关疾病的增加。因此，可以看出白内障手术治疗设备的需求正在增加，推动了增长的研究市场。

此外，根据 Konrad Pesudovs 等人于 2021 年 6 月发表的一项研究报告，到 2020 年，估计有 1520 万 50 岁以上的人将失明，另有 7880 万人将患有中度至重度白内障. 报导自 2000 年以来白内障失明的发病率增加了 29.7%，MSVI 病例增加了 93.1%。 因此，预计治疗白内障的手术数量将逐年增加，这有望在预测期内推动白内障手术器械市场的增长。

此外，众所周知，老年人白内障的患病率较高，随着人口老龄化，白内障负担预计将进一步增加，这有利于白内障手术器械市场的增长。产生影响。 例如，根据世界卫生组织 2021 年 10 月的更新，全球 60 岁及以上人口的比例将从 2015 年的 12% 增加到 2050 年的 22%，其中约 80% 据称生活在中低收入人群- 收入国家。 根据同一份文件，与衰老相关的常见健康状况包括听力损失、白内障和屈光不正，以及背痛和颈部疼痛。 此外，预计眼科医疗设备的技术进步将在预测期内进一步推动监控市场的增长。 然而，与白内障设备和手术相关的高成本预计将在研究预测期内限制白内障手术设备市场的增长。

主要市场趋势

在白内障手术器械市场，超声乳化器械细分市场预计在预测期内占据较大份额

超声波乳化机是目前治疗白内障最先进的设备之一，利用超声波乳化机，可以将晶状体用超声波乳化，然后吸出。 在白内障手术中，白内障手术是使用每秒振动超过 40,000 次的钛针通过 2.5 至 2.8 毫米的切口进行的。

超声乳化装置由于其相对于其他白内障手术的多项优势而在全球范围内广泛应用于眼科，白内障负担的增加导致其使用量有望进一步增加，这将推动该领域的增长。 白内障手术白内障超声乳化的主要优点是手术无需住院，不易因切口小而诱发散光，手术恢復快，日常生活不受限制。 因此，白内障手术首选超声乳化术。

此外，该领域领先公司在超声乳化系统方面的进步，以及新设备的推出，与其他公司在产品开发和营销方面的合作和伙伴关係，以及其他业务扩展努力，预计将推动增长的研究部分。 例如，2021 年 7 月，Johnson & Johnson Medical Devices Companies 旗下的 Johnson & Johnson Vision 将旨在解决三个关键领域：患者安全、外科医生效率和舒适度。宣布 VERITAS Vision System，下一代超声乳化（超声乳化）系统。 因此，由于上述因素，预计在本研究的预测期内，超声乳化设备部分将占白内障手术设备市场的主要份额。

在预测期内，预计北美地区将占据白内障手术器械市场的很大份额

按地区划分，由于白内障的沉重负担、先进和强大的医疗基础设施的存在以及人口老龄化的加剧等因素，预计北美地区将占据白内障手术设备市场的很大份额。是 例如，根据 2022 年 1 月的研究《加拿大视力障碍发病率：加拿大老龄化纵向研究》，加拿大白内障的发病率为 10.38%，不列颠哥伦比亚省的患病率最高，为 11.26%。随着该国老龄化人口的增加，预计加拿大的负担将进一步增加，从而随着该国老龄化人口的增加而增加该地区的白内障负担。这将导致白内障手术的增加，从而推动白内障手术器械市场的增长。

在北美地区，美国有望占据白内障手术市场的很大份额。 这是由于该国强大的医疗基础设施、更好的报销政策以及不断增长的老年人口导致的白内障负担沉重，导致该国白内障手术数量众多。 例如，根据美国疾病控制与预防中心 (CDC) 2020 年 6 月更新，约有 2050 万 40 岁以上的人（约占人口的 17.2%）的一隻或双眼患有白内障，到 2020 年底2020 预计到 2020 年，白内障总人数将增加到 3010 万，预计这将对国内进行的白内障手术数量产生重大影响，并推动监测市场的增长。 此外，随着该国老龄化率的上升，美国白内障手术器械市场有望在预测期内增长。 因此，在北美地区，由于上述因素，预计在本研究的预测期内，美国将在白内障手术器械市场占据重要市场份额。

竞争格局

白内障手术设备市场与几家主要参与者保持适度竞争。 此外，由于新技术的进步以及新产品和新举措的推出，预计市场竞争将加剧。 主要的市场领先公司包括 Coburn Technologies Inc.、Alcon Surgical Resources、Johnson & Johnson、NIDEK、Abbott、Ziemer Ophthalmic Systems、Carl Zeiss Meditech AG、Alcon, Inc.。

其他好处

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第一章介绍

  • 研究假设和市场定义
  • 调查范围

第二章研究方法论

第 3 章执行摘要

第四章市场动态

  • 市场概览
  • 市场驱动力
    • 白内障患病率上升和老年人口增加
    • 眼科设备技术进步
  • 市场製约因素
    • 白内障手术费用高昂
  • 波特的五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第五章市场细分（价值基础，单位：百万美元）

  • 按产品类型
    • 人工晶状体
    • 超声波乳化抽吸装置
    • 用于眼科的粘弹性装置
    • 其他
  • 最终用户
    • 眼科诊所
    • 医院
    • 其他
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东和非洲
      • 海湾合作委员会
      • 南非
      • 其他中东地区
    • 南美洲地区
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章竞争格局

  • 公司简介
    • Alcon, Inc.
    • Johnson & Johnson
    • Nidek Co., Ltd.
    • HAAG-Streit Holding AG
    • Ziemer Ophthalmic Systems
    • Carl Zeiss Meditech AG
    • Bausch & Lomb, Inc.
    • Iridex Corporation（Topcorn Corporation）
    • STAAR Surgical Company
    • Coburn Technologies Inc.
    • HumanOptics AG
    • GlaUnited Kingdomos Corporation
    • Sonomed Escalon

第7章 市场机会今后动向

简介目录
Product Code: 71260

The cataract surgery devices market is expected to register a CAGR of 4.2% during the forecast period of 2022-2027.

The COVID-19 pandemic led to disruption in not only the research and development activities of other therapies and drugs for medical conditions other than COVID-19 but also impacted the treatment procedures and supply chain of the pharmaceuticals and medical devices around the world, which also impacted the cataract surgery devices market. For instance, according to a research study published in December 2021, titled "Impact of COVID-19 Pandemic on Cataract Surgical Volume: A North Indian Experience", the studied clinic was expected to perform 7,500 cataract procedures, but due to the pandemic, they were able to perform only 2,500 procedures. This data suggests that there was a significant decrease in cataract procedures during the COVID-19 pandemic. However, with the ongoing vaccination programs and decreasing COVID-19 cases, the studied market is expected to regain its full potential over the forecast period of the study.

The major factors that are expected to drive growth in the cataract surgery devices market are the increasing prevalence of the cataract and the growing geriatric population globally. For instance, according to the research study published by Xiaotong Han et al., in September 2021, the global prevalence rate of cataract-related visual impairment increased by 58.45%, from 791.4 per 100,000 people in 1990 to 1,253.9 per 100,000 people in 2019, and the cataract-related disability-adjusted life years (DALYs) rate increased by 32.18 percent from 65.3 per 100,000 people in 1990 to 86.3 per 100,000 people in 2019, which shows an increase in cataract and cataract related illness, globally and thus, the demand for cataract surgery devices for treatment is increasing which is fueling growth in the studied market.

Further, according to the research study published by Konrad Pesudovs et. a., in June 2021, 2020, an estimated 15.2 million people aged 50 and more were blind, with another 78.8 million suffering from moderate to severe vision impairment (MSVI) due to cataract, and since 2000, there has been a 29.7% increase in the incidence of cataract blindness and a 93.1 percent increase in cases of MSVI. Hence, the number of surgeries for the treatment of cataracts is expected to increase over the years, which will drive growth in the cataract surgery devices market over the forecast period.

Moreover, the prevalence of cataracts is found to be higher in the older population, and with the growing geriatric population, the burden of cataracts is further expected to increase, which will have a positive impact on the growth of the cataract surgery devices market. For instance, according to the October 2021 update of the World Health Organization, the percentage of people of age more than 60 years in the global population will increase from 12% in 2015 to 22% by 2050, of which about 80% of the older people in 2050 will be living in the low-and middle-income countries. Also, as per the same source, the common heath conditions associated with aging includes hearing loss, cataracts and refractive errors, back and neck pain, and other. Also, technological advancements in ophthalmic devices are further expected to augment growth in the studied market over the forecast period of the study. However, the high cost associated with cataract devices and surgeries is expected to restrain growth in the cataract surgery devices market during the forecast period of the study.

Key Market Trends

Phacoemulsification Equipment Segment is Expected to Hold a Significant Share in the Cataract Surgery Devices Market Over the Forecast Period

Phacoemulsification systems are one of the most advanced types of equipment used in treating cataracts, and by using phacoemulsification equipment, the lens is emulsified with ultrasound before being suctioned out. With the help of phacoemulsification equipment, cataract surgery is performed through a 2.5 to 2.8 mm incision with the help of a titanium needle vibrating at the rate of more than 40,000 times per second.

The phacoemulsification systems offer several advantages over other cataract surgery procedures due to which this equipment is widely used in ophthalmology settings around the world, and with the increasing burden of cataracts, their usage is further expected to increase, which will boost growth in the segment. Some of the major benefits offered by phacoemulsification equipment in cataract surgery are no hospitalization required for surgery, small incision and lesser induced astigmatism because of the smaller incision, fast recovery from the surgery, and no restriction in daily routine. Hence, owing to these benefits, payers, and providers prefer a phacoemulsification system in cataract surgery.

In addition, the advancement in the phacoemulsification system by the key companies in the area along with the launch of new devices, collaboration, and partnerships with other companies for the development and marketing of the products, and other business expansion initiatives are expected to boost growth in the studied segment. For instance, in July 2021, Johnson & Johnson Vision, a part of the Johnson & Johnson Medical Devices Companies launched VERITAS Vision System, next-generation phacoemulsification (phaco) system designed to address three critical areas: patient safety, surgeon efficiency, and comfort. Therefore, due to these above-mentioned factors, the phacoemulsification equipment segment is expected to have a major share in the cataract surgery devices market during the forecast period of the study.

North America region is Expected to Occupy a Significant Share in the Cataract Surgery Devices Market Over the Forecast Period

By geography, the North American region is expected to hold a significant share in the cataract surgery devices market owing to the high burden of cataracts in the region, presence of advanced and robust healthcare infrastructure, growing aging population, and other factors. For instance, according to a research study in January 2022, titled "Incidence of visual impairment in Canada: the Canadian Longitudinal Study on Aging", the incidence of cataracts in Canada was 10.38%, with British Colombia being the region with the highest prevalence of 11.26% and the burden of cataract in Canada is further expected to increase with the growing geriatric population in the country, and hence with the growing geriatric population in the region, the burden of cataract is further expected to increase, leading to increase in several cataract surgeries and thus, driving growth in the cataract surgery devices market.

In the North American region, United States is expected to hold a major share in the cataract surgery devices market owing to a large number of cataract surgeries performed in the country due to its robust healthcare infrastructure, better reimbursement policies, and significant burden of cataract along with growing geriatric population. For instance, according to the June 2020 update of the Centers for Disease Control and Prevention (CDC), approximately 20.5 million (about 17.2% of the total population) of age 40 years and more had cataracts in one or both eyes, and it was estimated that by the end of 2020, the total number of people who have cataracts is estimated to increase to 30.1 million, which is expected to have a significant impact on the number of cataract surgeries performed in the country and boost growth in the studied market. Further, with the growing aging population of the country, the cataract surgery devices market in United States is expected to grow over the forecast period. Therefore, due to the above-mentioned factors, in the North American region, United States is expected to have a significant market share in the cataract surgery devices market during the forecast period of the study.

Competitive Landscape

The cataract surgery devices market is moderately competitive, with several major players in the area. Also, the new technological advancements and launch of new products and initiatives are expected to make the market more competitive. Some of the key companies leading the market are Coburn Technologies Inc., Alcon Surgical Resources, Johnson & Johnson, NIDEK, Abbott, Ziemer Ophthalmic Systems, Carl Zeiss Meditech AG, and Alcon, Inc., among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increase in Prevalence of Cataract Diseases and Increasing Geriatric Population
    • 4.2.2 Technological Advancements in Ophthalmic Devices
  • 4.3 Market Restraints
    • 4.3.1 High Cost Incurred for Cataract Surgeries
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - in USD Million)

  • 5.1 By Product Type
    • 5.1.1 Intraocular Lenses
    • 5.1.2 Phacoemulsification Equipment
    • 5.1.3 Ophthalmic Viscoelastic Devices
    • 5.1.4 Others
  • 5.2 By End-User
    • 5.2.1 Ophthalmology Clinics
    • 5.2.2 Hospitals
    • 5.2.3 Others
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Alcon, Inc.
    • 6.1.2 Johnson & Johnson
    • 6.1.3 Nidek Co., Ltd.
    • 6.1.4 HAAG-Streit Holding AG
    • 6.1.5 Ziemer Ophthalmic Systems
    • 6.1.6 Carl Zeiss Meditech AG
    • 6.1.7 Bausch & Lomb, Inc.
    • 6.1.8 Iridex Corporation (Topcorn Corporation)
    • 6.1.9 STAAR Surgical Company
    • 6.1.10 Coburn Technologies Inc.
    • 6.1.11 HumanOptics AG
    • 6.1.12 Glaukos Corporation
    • 6.1.13 Sonomed Escalon

7 MARKET OPPORTUNITIES AND FUTURE TRENDS